Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.
about
Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateA method for identification and analysis of non-overlapping myeloid immunophenotypes in humansImproving cancer immunotherapy by targeting the STATe of MDSCsTumor-induced myeloid dysfunction and its implications for cancer immunotherapyImmune signature of tumor infiltrating immune cells in renal cancer.Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patientsThe interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostaComprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study.Functional analysis of CD14+HLA-DR-/low myeloid-derived suppressor cells in patients with lung squamous cell carcinoma.Progress and opportunities for immune therapeutics in osteosarcoma.Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases.CD14+CD15-HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes.Dendritic cell control of immune responses.MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma.Genetics and biology of prostate cancer
P2860
Q26777205-80EA52C7-FF78-442E-A3C3-E738E3B64F13Q27310807-58E8D01C-DFB5-4412-B9E3-441D5CE0A0AFQ28066797-8F86C537-9A89-4DC9-BD9C-17CE9567E3E7Q34810257-07312A45-B6B1-4CDD-808E-C846274ABE31Q35201895-2DE3C4E6-3549-476E-BC1D-B69BD2202427Q35965142-B023AB21-527D-4C9C-A077-EF45ABCC5F7AQ37477372-20B9DD17-2324-4F1C-9FAA-FA9500A43216Q38662119-F67C50DB-FC93-4250-9E20-4BF7D532D34AQ38673785-C3017583-4AB0-4A88-AC0A-23C496E4F401Q38697689-4E0B1727-7C21-49BA-AC86-D188D5C682BEQ38948905-BD5F180A-B063-4237-B055-17719203090DQ39130451-B7B1FD68-DF00-4F28-87DC-3A01B50AD544Q39369955-BA883393-62C6-4D84-828C-03DB8A61A478Q39412983-FB862518-1801-47A4-9210-4A94B2CD23E0Q40180993-634ED0A0-B3AF-4538-9F5D-468B4740CB95Q41573313-A3620215-DBB2-4EED-9A33-5B1E03686CEBQ43090726-AF5755EC-D84D-4F66-8AD8-01D491D82A14Q43134012-9DC8A724-BF7E-42C4-8957-CD0996A9202EQ48306861-ABE6D719-4ADF-4D17-A9B6-7D0D595CDDE0Q49694802-34886FA3-4FFB-4038-B41E-A068F01C0899Q55360157-D82A3CCE-B755-4147-AE74-CBAB229119F3Q57106917-16F3251B-6BD1-4A02-9092-245675180AD1
P2860
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer Vaccines in the World o ...... Gateway to Improved Responses.
@en
type
label
Cancer Vaccines in the World o ...... Gateway to Improved Responses.
@en
prefLabel
Cancer Vaccines in the World o ...... Gateway to Improved Responses.
@en
P2093
P2860
P356
P1476
Cancer Vaccines in the World o ...... Gateway to Improved Responses.
@en
P2093
Michael P Gustafson
Peggy A Bulur
Rebecca R Laborde
P2860
P356
10.3389/FIMMU.2014.00147
P577
2014-04-04T00:00:00Z